Literature DB >> 30204418

Targeted LC-MS/MS Proteomics-Based Strategy To Characterize in Vitro Models Used in Drug Metabolism and Transport Studies.

Meijuan Xu1,2, Neha Saxena1, Marc Vrana1, Haeyoung Zhang1, Vineet Kumar1, Sarah Billington1, Cyrus Khojasteh3, Scott Heyward4, Jashvant D Unadkat1, Bhagwat Prasad1.   

Abstract

Subcellular fractionation of tissue homogenate provides enriched in vitro models (e.g., microsomes, cytosol, or membranes), which are routinely used in the drug metabolism or transporter activity and protein abundance studies. However, batch-to-batch or interlaboratory variability in the recovery, enrichment, and purity of the subcellular fractions can affect performance of in vitro models leading to inaccurate in vitro to in vivo extrapolation (IVIVE) of drug clearance. To evaluate the quality of subcellular fractions, we developed a simple, targeted, and sensitive LC-MS/MS proteomics-based strategy, which relies on determination of protein markers of various cellular organelles, i.e., plasma membrane, cytosol, nuclei, mitochondria, endoplasmic reticulum (ER), lysosomes, peroxisomes, cytoskeleton, and exosomes. Application of the quantitative proteomics method confirmed a significant effect of processing variables (i.e., homogenization method and centrifugation speed) on the recovery, enrichment, and purity of isolated proteins in microsomes and cytosol. Particularly, markers of endoplasmic reticulum lumen and mitochondrial lumen were enriched in the cytosolic fractions as a result of their release during homogenization. Similarly, the relative recovery and composition of the total membrane fraction isolated from cell vs tissue samples was quantitatively different and should be considered in IVIVE. Further, analysis of exosomes isolated from sandwich-cultured hepatocyte media showed the effect of culture duration on compositions of purified exosomes. Therefore, the quantitative proteomics-based strategy developed here can be applied for efficient and simultaneous determination of multiple protein markers of various cellular organelles when compared to antibody- or activity-based assays and can be used for quality control of subcellular fractionation procedures including in vitro model development for drug metabolism and transport studies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30204418      PMCID: PMC6414395          DOI: 10.1021/acs.analchem.8b01913

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  46 in total

Review 1.  Structure, function and regulation of carboxylesterases.

Authors:  Tetsuo Satoh; Masakiyo Hosokawa
Journal:  Chem Biol Interact       Date:  2006-07-06       Impact factor: 5.192

2.  Global, quantitative and dynamic mapping of protein subcellular localization.

Authors:  Daniel N Itzhak; Stefka Tyanova; Jürgen Cox; Georg Hh Borner
Journal:  Elife       Date:  2016-06-09       Impact factor: 8.140

3.  Variability in Mass Spectrometry-based Quantification of Clinically Relevant Drug Transporters and Drug Metabolizing Enzymes.

Authors:  Christine Wegler; Fabienne Z Gaugaz; Tommy B Andersson; Jacek R Wiśniewski; Diana Busch; Christian Gröer; Stefan Oswald; Agneta Norén; Frederik Weiss; Helen S Hammer; Thomas O Joos; Oliver Poetz; Brahim Achour; Amin Rostami-Hodjegan; Evita van de Steeg; Heleen M Wortelboer; Per Artursson
Journal:  Mol Pharm       Date:  2017-08-16       Impact factor: 4.939

Review 4.  Calreticulin: one protein, one gene, many functions.

Authors:  M Michalak; E F Corbett; N Mesaeli; K Nakamura; M Opas
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

5.  Application of an LC-MS/MS method for the simultaneous quantification of human intestinal transporter proteins absolute abundance using a QconCAT technique.

Authors:  M D Harwood; B Achour; M R Russell; G L Carlson; G Warhurst; A Rostami-Hodjegan
Journal:  J Pharm Biomed Anal       Date:  2015-02-28       Impact factor: 3.935

6.  Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data.

Authors:  Helen E Cubitt; J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2011-02-08       Impact factor: 3.922

7.  In Vitro-In Vivo Extrapolation Scaling Factors for Intestinal P-glycoprotein and Breast Cancer Resistance Protein: Part II. The Impact of Cross-Laboratory Variations of Intestinal Transporter Relative Expression Factors on Predicted Drug Disposition.

Authors:  Matthew D Harwood; Brahim Achour; Sibylle Neuhoff; Matthew R Russell; Gordon Carlson; Geoffrey Warhurst; Amin Rostami-Hodjegan
Journal:  Drug Metab Dispos       Date:  2016-02-03       Impact factor: 3.922

8.  Changes in the cytoplasmic (lactate dehydrogenase) and plasma membrane (acetylcholinesterase) marker enzymes in the synaptic and nonsynaptic mitochondria derived from rats with moderate hyperammonemia.

Authors:  L Faff-Michalak; J Albrecht
Journal:  Mol Chem Neuropathol       Date:  1993-04

9.  Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants.

Authors:  Mikael Boberg; Marc Vrana; Aanchal Mehrotra; Robin E Pearce; Andrea Gaedigk; Deepak Kumar Bhatt; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2016-11-28       Impact factor: 3.922

10.  Microsomal and Cytosolic Scaling Factors in Dog and Human Kidney Cortex and Application for In Vitro-In Vivo Extrapolation of Renal Metabolic Clearance.

Authors:  Daniel Scotcher; Sarah Billington; Jay Brown; Christopher R Jones; Colin D A Brown; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2017-03-07       Impact factor: 3.922

View more
  10 in total

1.  Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper.

Authors:  Bhagwat Prasad; Brahim Achour; Per Artursson; Cornelis E C A Hop; Yurong Lai; Philip C Smith; Jill Barber; Jacek R Wisniewski; Daniel Spellman; Yasuo Uchida; Michael A Zientek; Jashvant D Unadkat; Amin Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2019-07-26       Impact factor: 6.875

2.  Parameterization of Microsomal and Cytosolic Scaling Factors: Methodological and Biological Considerations for Scalar Derivation and Validation.

Authors:  Michael J Doerksen; Robert S Jones; Michael W H Coughtrie; Abby C Collier
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-12-19       Impact factor: 2.441

3.  Contributions of Cathepsin A and Carboxylesterase 1 to the Hydrolysis of Tenofovir Alafenamide in the Human Liver, and the Effect of CES1 Genetic Variation on Tenofovir Alafenamide Hydrolysis.

Authors:  Jiapeng Li; Jian Shi; Jingcheng Xiao; Lana Tran; Xinwen Wang; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2021-12-21       Impact factor: 3.922

Review 4.  Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine.

Authors:  Deepak Ahire; Laken Kruger; Sheena Sharma; Vijaya Saradhi Mettu; Abdul Basit; Bhagwat Prasad
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 5.  Applications of Tandem Mass Spectrometry (MS/MS) in Protein Analysis for Biomedical Research.

Authors:  Anca-Narcisa Neagu; Madhuri Jayathirtha; Emma Baxter; Mary Donnelly; Brindusa Alina Petre; Costel C Darie
Journal:  Molecules       Date:  2022-04-08       Impact factor: 4.927

6.  Targeted quantitative proteomic analysis of drug metabolizing enzymes and transporters by nano LC-MS/MS in the sandwich cultured human hepatocyte model.

Authors:  Raju Khatri; John K Fallon; Rebecca J B Rementer; Natasha T Kulick; Craig R Lee; Philip C Smith
Journal:  J Pharmacol Toxicol Methods       Date:  2019-05-31       Impact factor: 1.950

7.  Interindividual Variability and Differential Tissue Abundance of Mitochondrial Amidoxime Reducing Component Enzymes in Humans.

Authors:  Deepak Ahire; Abdul Basit; Lisa J Christopher; Ramaswamy Iyer; J Steven Leeder; Bhagwat Prasad
Journal:  Drug Metab Dispos       Date:  2021-12-23       Impact factor: 3.922

8.  Ultrasensitive Quantification of Drug-metabolizing Enzymes and Transporters in Small Sample Volume by Microflow LC-MS/MS.

Authors:  Deepak Suresh Ahire; Abdul Basit; Matthew Karasu; Bhagwat Prasad
Journal:  J Pharm Sci       Date:  2021-03-28       Impact factor: 3.784

9.  Influence of Proteome Profiles and Intracellular Drug Exposure on Differences in CYP Activity in Donor-Matched Human Liver Microsomes and Hepatocytes.

Authors:  Christine Wegler; Pär Matsson; Veronica Krogstad; Jozef Urdzik; Hege Christensen; Tommy B Andersson; Per Artursson
Journal:  Mol Pharm       Date:  2021-03-19       Impact factor: 4.939

Review 10.  Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development.

Authors:  Yurong Lai; Xiaoyan Chu; Li Di; Wei Gao; Yingying Guo; Xingrong Liu; Chuang Lu; Jialin Mao; Hong Shen; Huaping Tang; Cindy Q Xia; Lei Zhang; Xinxin Ding
Journal:  Acta Pharm Sin B       Date:  2022-03-17       Impact factor: 14.903

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.